Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Mylan Institutional, Inc.
Subpotent and Superpotent Drug
PREGABALIN
Product quality - Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or …
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Viatris Inc
Superpotent Drug and Subpotent Drug: potency failures obtained
Endo USA, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Evaric Pharmaceuticals Inc.
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Amerisource Health Services LLC
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Amerisource Health Services LLC
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Zydus Pharmaceuticals (USA) Inc
Labeling: Not Elsewhere Classified - Wrong NDC number
Amerisource Health Services LLC
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
LNK International, Inc.
CGMP Deviations: Released product should have been rejected.
Keystone Industries
CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…
Keystone Industries
CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…